GCIA
ONCE

Gabelli & Co Investment Advisers’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-259,491
Closed -$25.2M – 224
2019
Q3 		$25.2M Sell
259,491
-32,233
-11% -$3.23M 2.83% 11
2019
Q2 		$29.9M Buy
291,724
+21,413
+8% +$2.31M 3.2% 7
2019
Q1 		$30.8M Buy
+270,311
New +$19.9M 3.96% 7

Gabelli & Co Investment Advisers's ONCE Position: Q4 2019 in Review

Gabelli & Co Investment Advisers sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 259,491 shares — an estimated $25.2M sold.

Gabelli & Co Investment Advisers first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $30.8M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Gabelli & Co Investment Advisers reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 259,491 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $25.2M.
  • Gabelli & Co Investment Advisers first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
  • Gabelli & Co Investment Advisers's Spark Therapeutics, Inc. Common Stock position peaked at $30.8M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.